A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01838668 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05147220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

NCT01127750 ·Status: COMPLETED ·Phase: PHASE3

ATX-MS-1467 in Multiple Sclerosis

NCT01973491 ·Status: COMPLETED ·Phase: PHASE2

Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects

NCT01624714 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of BG00012 in MS

NCT00168701 ·Status: COMPLETED ·Phase: PHASE2

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

NCT02746744 ·Status: COMPLETED ·Phase: PHASE3

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

NCT03889639 ·Status: COMPLETED ·Phase: PHASE2

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

NCT04602390 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

NCT00879658 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

NCT01199640 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

NCT02792218 ·Status: COMPLETED ·Phase: PHASE3

Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis

NCT02472938 ·Status: WITHDRAWN ·Phase: PHASE4

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

NCT04171310 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

NCT00420212 ·Status: COMPLETED ·Phase: PHASE3

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

NCT02601885 ·Status: COMPLETED ·Phase: PHASE1

A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

NCT05083923 ·Status: COMPLETED ·Phase: PHASE3

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

NCT00835770 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

NCT02792231 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

NCT04670770 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

NCT02048358 ·Status: TERMINATED ·Phase: PHASE1

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

NCT01020370 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

NCT06735248 ·Status: RECRUITING ·Phase: PHASE2